Showing results (221-230 of 583) with videos related to
Sort By:
Pageof 59
Mechanisms of Development|July 20, 2002
Novel SOX9 expression during human pancreas development correlates to abnormalities in Campomelic dysplasiaK Piper, S G Ball, J W Keeling, et al.BJOG : an International Journal of Obstetrics and Gynaecology|February 21, 2006
The Scottish Perinatal Neuropathology Study--clinicopathological correlation in stillbirthsJ-C Becher, J E Bell, J W Keeling, et al.Journal of Chemical Information and Computer Sciences|May 28, 2003
Text Influenced Molecular Indexing (TIMI): a literature database mining approach that handles text and chemistrySuresh B Singh, Richard D Hull, Eugene M FluderHaemostasis|March 9, 1999
The economic impact of treating deep vein thrombosis with low-molecular-weight heparin: outcome of therapy and health economy aspectsR D Hull, G F Pineo, G E RaskobThe American Journal of Medicine|September 21, 2000
Withholding treatment in patients with acute pulmonary embolism who have a high risk of bleeding and negative serial noninvasive leg testsP D Stein, R D Hull, G E RaskobClinics in Chest Medicine|November 5, 2010
Established venous thromboembolism therapies: heparin, low molecular weight heparins, and vitamin K antagonists, with a discussion of heparin-induced thrombocytopeniaRobert C Pendleton, George M Rodgers, Russell D HullBrain Research|July 4, 1983
Intracellular studies of the convergence of sensory input on caudate neurons of catJ S Wilson, C D Hull, N A BuchwaldJournal of Neuro-Oncology|January 1, 1994
Prophylaxis of venous thromboembolism in brain tumor patientsM G Hamilton, R D Hull, G F PineoSeminars in Thrombosis and Hemostasis|December 5, 1998
Treatment and prevention of venous thromboembolismR D Hull, G F Pineo, K A ValentineSeminars in Thrombosis and Hemostasis|January 1, 1997
Low-molecular-weight heparin therapy and mortalityK A Valentine, R D Hull, G F PineoPageof 59